Lectures 3 and 4 Flashcards
Agonist
Drug that binds to and activates receptor
Can be full, partial or inverse
Allosteric modulator
Drug that binds to receptor at a site distinct from the active site. Induces a conformational change in the receptor, which alters the affinity of the receptor for the endogenous ligand.
Antagonist
A drug that attenuates the effect of an agonist
Can be competitive or non-competitive, each of which can be reversible or irreversible
Bmax
The maximum amount of drug or radioligand, usually expressed as picomoles per mg protein, which can specifically bind to receptors in a membrane preparation
Cheng-Prusoff equation
Used to determine the Ki value from an IC50 value measured in a competition radioligand binding assay
Desensitisation
A reduction in response to an agonist while it is continuously present at the receptor
EC50
The molecular concentration of an agonist that produces 50% of the maximum possible response for that agonist
ED50
Dose of drug that produces 50% of its maximum response or effect
Efficacy
The way that agonists vary in the response they produce when they occupy the same number of receptors
High efficacy agonists produce their maximal response while occupying a relatively low proportion of the total receptor population
Lower efficacy agonists do not activate receptors to the same degree and may not be able to produce the maximal response
Half life
Important pharmacokinetic measurement
Time taken for a drug’s concentration in plasma to decline to half its original level
IC50
Concentration of an agonist or antagonist which produces 50% of its maximum possible inhibition
ID50
Dose of a drug needed to cause 50% of the maximum possible inhibition of that drug
Kd
The dissociation constant for a radio labelled drug determined by saturation analysis
It is the molar concentration of radioligand which, at equilibrium, occupies 50% of the receptors
Ki
The inhibition constant for a ligand, which donates the affinity of the ligand for a receptor
Non-specific binding
The proportion of radioligand that is not displaced by other competitive ligands specific for the receptor
pA2
Measure of potency of antagonist
It is the negative logarithm of the molar concentration of an antagonist that would produce a 2-fold shift in the concentration response curve for an agonist
p before abbreviation
Negative logarithm
Specific binding
The proportion of radioligand that can be displaced by competitive ligands specific to the receptor
LGIC
Ionotrophic
Typically at site where fast NTs act
Eg. GABA, nAchR, Glu
Structure of LGIC
Homo or hetero
3-5 subunits around central pore
Families of LGIC
Cys loop type- pentamers eg nAchR
NMDA type- tetramers
P2X type- trainers
Eg P2XR
Why is the gut useful in pharmacology?
Contains many receptors that are the same as those in the brain
Propanalol is an example of
Reversible competitive antagonist
Competes with isoprenaline